since february 1987 to july 1988 , 133 patients with advanced gastric cancer have been prospectively randomized to receive either mf ( methotrexate 100 mg/m2 i.v . push , 5-fluorouracil 600 mg/m2 i.v . drip over 15 minutes one hour after methotrexate and leucovorin 15 mg p.o . q 6 hrs x 2 beginning 24 hrs after methotrexate ) of f ( the same 5-fluorouracil as described for mf ) .
C0016360
fluorouracil
C0280603
mf